• In the first quarter of 2026, Plains GP Holdings, L.P. reported revenue of US$12.47 billion, net income of US$20 million, and basic earnings per share from continuing operations of US$0.24, while also updating investors on progress with NGL asset sales and Cactus III integration.
• Alongside these results, the company raised its full-year 2026 adjusted EBITDA guidance midpoint to US$2.88 billion and added experienced energy executive Cynthia B. Taylor to its board and key committees, underscoring a focus on operational execution and governance.
• With this higher adjusted EBITDA outlook now on the table, we will examine how it reshapes Plains GP Holdings' existing investment narrative.

We've uncovered the 14 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Plains GP Holdings Investment Narrative Recap

To own Plains GP Holdings today, you need to believe its shift toward a focused crude oil midstream platform can support stable, fee-based cash flows despite energy transition and Permian concentration risks. The Q1 2026 update, including higher full year adjusted EBITDA guidance of US$2.88 billion, supports the near term catalyst around execution on NGL divestitures and Cactus III integration, while the main immediate risk remains potential margin pressure as contracts renew and the asset mix becomes more concentrated.

The most relevant recent development here is the raised 2026 adjusted EBITDA guidance following Q1 results, tied to progress on NGL asset sales and Cactus III integration. This guidance increase directly connects to the core catalyst of simplifying the portfolio and focusing capital on crude systems, while also testing whether the market is comfortable with higher earnings concentration in crude oil and the Permian at a time when regulatory and energy transition pressures remain in the background.

Yet behind the higher EBITDA outlook, investors should be aware of how contract repricing and Permian dependence could affect Plains GP Holdings if...

Plains GP Holdings' narrative projects $50.0 billion revenue and $394.5 million earnings by 2029.

Uncover how Plains GP Holdings' forecasts yield a $22.57 fair value, a 4% downside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were previously assuming revenue of about US$57.9 billion and earnings near US$339.9 million by 2028, which is a much more bullish story than consensus and leans heavily on stronger Permian driven volume growth and higher margins. After this quarter’s guidance change, you may find that these upbeat views on fee based growth and regulatory barriers look either more achievable or more stretched, so it is worth comparing how your own expectations line up with these different scenarios.

Explore 5 other fair value estimates on Plains GP Holdings - why the stock might be worth over 4x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your Plains GP Holdings research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
• Our free Plains GP Holdings research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Plains GP Holdings' overall financial health at a glance.

No Opportunity In Plains GP Holdings?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• Outshine the giants: these 16 early-stage AI stocks could fund your retirement.
• This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.
• The future of work is here. Discover the 31 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.